Resultado de búsqueda
23 de ago. de 2022 · The USPSTF recommends that clinicians prescribe a statin for the primary prevention of CVD for adults aged 40 to 75 years who have 1 or more CVD risk factors (i.e. dyslipidemia, diabetes, hypertension, or smoking) and an estimated 10-year risk of a cardiovascular event of 10% or greater. B.
Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion.
10 de feb. de 2019 · The USPSTF recommended preventive statin use for individuals between the ages of 40 and 75 who have a risk factor for cardiovascular disease such as high blood pressure and 10% or greater 10-year calculated risk of a cardiovascular event.
high-intensity statin therapy or maximally tolerated statin therapy. The more LDL-C is -sequent risk reduction. Use a maximally tolerated statin to lower LDL-C levels by ≥50%. 3. In very high-risk ASCVD, use a LDL-C thresh-old of 70 mg/dL (1.8 mmol/L) to consider addition of nonstatins to statin therapy. Very
The USPSTF recommends statins in individuals above the 10% threshold and with 1 or more CVD risk factors (B recommendation). Between a 10-year CVD risk of 7.5% to less than 10% risk and with 1 or more CVD risk factors, the USPSTF recommends selectively offering statins (C recommendation).
21 de feb. de 2017 · The USPSTF recommended preventive statin use for individuals between the ages of 40 and 75 who have a risk factor for cardiovascular disease such as high blood pressure and 10% or greater 10-year calculated risk of a cardiovascular event.
The Task Force recommends people ages 40 to 75 at high risk for CVD take a statin to prevent a first heart attack or stroke. People ages 40 to 75 who are at increased risk, but not at high risk, should decide with their healthcare professional whether to take a statin.
